Will I Get Paid if I Participate in a Clinical Trial for MBC?
Click to learn about money you may receive if you participate in a clinical trial, including whether you will be paid.
Experts Weigh in on MBC Subtypes: Triple Negative MBC, Including HER2-Low and HER2-Ultralow
This month, we highlight the latest expert opinions on treatments for triple negative and HER2-low and -ultralow MBC and unanswered questions that need to be answered in clinical trials. Click to learn more about clinical trials for this subtype of MBC.
FDA Expands Approval for Enhertu®
The FDA expanded approval for fam-trastuzumab deruxtecan-nxki (Enhertu®) in combination with pertuzumab (Perjeta®) as first-line treatment of people with HER2+ MBC. Click to learn more about this new approval.
The Importance of Diversity in MBC Clinical Trials
Diversity in clinical trials is good science and helps doctors know how treatments will work in all types of people who will receive them. Read below to learn more about why diversity in clinical trials benefits everyone.
Experts Weigh in on MBC Subtypes: Hormone Receptor-Positive MBC
This month, we highlight the latest expert opinions on treatments for HR+ MBC and unanswered questions that need to be answered in clinical trials. Click to learn more about clinical trials for this subtype of MBC.
Research for Metastatic Inflammatory Breast Cancer
Inflammatory breast cancer (IBC) is a rare type of breast cancer. Click to learn more about recent research and clinical trials for metastatic IBC.
What Should I do if I Decide to Leave a Clinical Trial?
If you enroll in a clinical trial, you have the right to leave at any time for any reason. Read below to learn more about leaving a clinical trial and steps to consider.
What Should I do if I Decide to Leave a Clinical Trial?
If you enroll in a clinical trial, you have the right to leave at any time for any reason. Read below to learn more about leaving a clinical trial and steps to consider.
Getting a Second Opinion About Your MBC
Getting a second opinion at any step of your care journey can help you understand your options for care, which may include clinical trials. Learn more about when, how, and why to get a second opinion and how to find relevant trials
FDA Approves Inluriyo™
Read about the recent approval of Inluriyo™ for some people with ER-positive, HER2-negative MBC with an ESR1 gene mutation.